For 150 years, Boston Children’s has embodied a culture of scientific investigation that has shaped pediatric medicine and changed children’s lives. This legacy continues today as we lead the world in pediatric research, empowering clinicians and scientists to challenge the status quo and seek better answers for our patients.
Our research enterprise is the world's largest and most highly-funded pediatric hospital. In FY2018, we received more funding from the National Institutes of Health than any other children’s hospital in the nation. We perform research in a vast range of specialties, revolutionizing treatments for children with common conditions, such as asthma, diabetes and obesity, to children with rare and complex disorders.
Boston Children's leads or participates in hundreds of clinical trials. Use this database to find out which trials are recruiting, who can enroll and more.
A central hub of resources to support the Boston Children’s research community through guidance on planning, designing, implementing and reporting.
Manny Johnson, 21, previously required monthly blood transfusions to keep his severe sickle cell disease under control. After receiving a new gene therapy treatment, he’s been symptom-free for six months.
The study, published in the Journal of Neurosurgery Pediatrics, is one of the first randomized prospective trials to directly compare antibiotic and non-antibiotic shunts in children.
The Robert’s Program at Boston Children’s is adding a genetic approach to the search for answers for children with sudden unexplained deaths in pediatrics (SUDP).
© 2005-2019 All Rights Reserved
